Sophie Bellanger - Concepedia

Author

Sophie Bellanger

Agency for Science, Technology and Research ORCID

Also Known As

Bellanger, Sophie, S Bellanger, S. Bellanger, Sophie Bellanger, Stéphane Bellanger

Publications

851

Citations

H-Index

Concepts

All Affiliations

Agency for Science, Technology and Research Institute of Medical Biology Procter & Gamble (United States)Centre National de la Recherche Scientifique National Skin Centre

About

Sophie Bellanger is an author at Agency for Science, Technology and Research specializing in cell biology, medicine, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	366
2	Cell Biology	8	8	366
3	Natural Sciences	3	3	143
4	Public Health	2	2	150
5	Biochemistry	1	1	77

Sophie Bellanger

Publications

759

Citations

H-Index

Page 1

	Year	Citations
HPV16 E2 Is an Immediate Early Marker of Viral Infection, Preceding E7 Expression in Precursor Structures of Cervical Carcinoma Yuezhen Xue, Sophie Bellanger, Wenying Zhang, Cancer Research E7 ExpressionImmunologyPathologyHpv InfectionTumor Biology	2010	96
High-Risk But Not Low-Risk HPV E2 Proteins Bind to the APC Activators Cdh1 and Cdc20 and Cause Genomic Instability Sophie Bellanger, Stéphanie Blachon, Francisca Méchali, Cell Cycle	2005	79
Localization of HPV-18 E2 at Mitochondrial Membranes Induces ROS Release and Modulates Host Cell Metabolism Deborah Lai, Chye Ling Tan, Jayantha Gunaratne, PLoS ONE Mitochondrial E2 AssociationInner Mitochondrial MembraneMolecular BiologyCell DeathPathology	2013	77
Nucleo-cytoplasmic Shuttling of High Risk Human Papillomavirus E2 Proteins Induces Apoptosis Stéphanie Blachon, Sophie Bellanger, Caroline Demeret, Journal of Biological Chemistry	2005	74
Cyclin B2 suppresses mitotic failure and DNA re-replication in human somatic cells knocked down for both cyclins B1 and B2 Sophie Bellanger, Armand de Gramont, Joëlle Sobczak‐Thépot Oncogene ChromatinGenome InstabilityMitotic FailureCell DivisionCyclins B1	2007	55
Stability of the Human Papillomavirus Type 18 E2 Protein Is Regulated by a Proteasome Degradation Pathway through Its Amino-Terminal Transactivation Domain Sophie Bellanger, Caroline Demeret, Sylvain Goyat, Journal of Virology	2001	55
Nicotinamide Metabolism Modulates the Proliferation/Differentiation Balance and Senescence of Human Primary Keratinocytes Chye Ling Tan, Toby Chin, Christina Yan Ru Tan, Journal of Investigative Dermatology	2019	55
Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression. Sophie Bellanger, Chye Ling Tan, Yue Xue, PubMed Viral ReplicationCervical Cancer ProgressionHpv-induced CarcinogenesisPathologyMolecular Biology	2011	54
Nicotinamide Prevents UVB- and Oxidative Stress‒Induced Photoaging in Human Primary Keratinocytes Christina Yan Ru Tan, Chye Ling Tan, Toby Chin, Journal of Investigative Dermatology	2021	51
The Human Papillomavirus Type 18 E2 Protein Is a Cell Cycle-Dependent Target of the SCF <sup>Skp2</sup> Ubiquitin Ligase Sophie Bellanger, Chye Ling Tan, Wen Long Nei, Journal of Virology Cell RegulationCell DivisionHuman Papillomavirus VaccinesCell Cycle-dependent TargetE2 Gene	2009	37

Page 1